TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Polypeptide Laboratories Holding (PPL) AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,177,280
|
1,164,553
|
885,421 |
| Financial expenses |
119,260
|
84,262
|
29,118 |
| Earnings before taxes |
-225,378
|
-223,072
|
-141,497 |
| EBITDA |
-183,888
|
-383,563
|
-112,097 |
| Total assets |
3,167,181
|
2,945,595
|
2,000,653 |
| Current assets |
864,464
|
1,005,143
|
388,015 |
| Current liabilities |
1,357,432
|
879,450
|
567,972 |
| Equity capital |
211,521
|
278,299
|
365,994 |
| - share capital |
134
|
134
|
134 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
6.7%
|
9.4%
|
18.3% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-19.1%
|
-19.2%
|
-16.0% |
| Return on assets (ROA) |
-3.4%
|
-4.7%
|
-5.6% |
| Current ratio |
63.7%
|
114.3%
|
68.3% |
| Return on equity (ROE) |
-106.6%
|
-80.2%
|
-38.7% |
| Change turnover |
51,246
|
274,572
|
289,239 |
| Change turnover % |
5%
|
31%
|
49% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.